(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
Live Chart Being Loaded With Signals
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development...
Stats | |
---|---|
Today's Volume | 192 108 |
Average Volume | 1.36M |
Market Cap | 4.40B |
EPS | £0 ( 2024-02-25 ) |
Last Dividend | £12.50 ( 2023-03-09 ) |
Next Dividend | £0 ( N/A ) |
P/E | -154.64 |
ATR14 | £15.19 (0.39%) |
Volume Correlation
Dechra Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
BUR.L | 0.808 |
10 Most Negative Correlations | |
---|---|
DMGT.L | -0.834 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dechra Pharmaceuticals Correlation - Currency/Commodity
Dechra Pharmaceuticals Financials
Annual | 2022 |
Revenue: | £761.50M |
Gross Profit: | £426.30M (55.98 %) |
EPS: | £-0.240 |
Q4 | 2022 |
Revenue: | £192.05M |
Gross Profit: | £105.55M (54.96 %) |
EPS: | £-0.220 |
Q3 | 2022 |
Revenue: | £192.05M |
Gross Profit: | £105.55M (54.96 %) |
EPS: | £-0.220 |
Q2 | 2022 |
Revenue: | £188.70M |
Gross Profit: | £109.25M (57.90 %) |
EPS: | £0.0993 |
Financial Reports:
No articles found.
Dechra Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£32.89 (N/A) |
£12.50 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.133 | 2001-03-07 |
Last Dividend | £12.50 | 2023-03-09 |
Next Dividend | £0 | N/A |
Payout Date | 2023-04-13 | |
Next Payout Date | N/A | |
# dividends | 45 | -- |
Total Paid Out | £356.25 | -- |
Avg. Dividend % Per Year | 0.54% | -- |
Score | 2.05 | -- |
Div. Sustainability Score | 3.80 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 1.261 | -- |
Year | Amount | Yield |
---|---|---|
2001 | £0 | 0.00% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £25.50 | 0.92% |
2019 | £31.60 | 1.51% |
2020 | £34.29 | 1.17% |
2021 | £40.50 | 1.14% |
2022 | £44.89 | 0.94% |
2023 | £12.50 | 0.48% |
2024 | £0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SQZ.L | Dividend Knight | 2023-10-26 | Annually | 5 | 3.33% | |
JSG.L | Dividend Knight | 2023-10-05 | Annually | 32 | 0.64% | |
CCC.L | Dividend Knight | 2023-09-28 | Semi-Annually | 26 | 1.57% | |
POLR.L | Dividend King | 2023-07-06 | Semi-Annually | 18 | 4.22% | |
GEM.L | Dividend King | 2023-04-27 | Semi-Annually | 3 | 7.30% | |
ALFA.L | Dividend King | 2023-09-14 | Semi-Annually | 5 | 3.78% | |
THS.L | Dividend Knight | 2023-06-08 | Annually | 7 | 3.10% | |
LTHM.L | Dividend Knight | 2023-08-03 | Semi-Annually | 33 | 0.87% | |
CPG.L | Dividend Knight | 2023-06-08 | Annually | 24 | 0.87% | |
RKT.L | Dividend Knight | 2023-08-03 | Semi-Annually | 23 | 1.95% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0366 | 1.500 | -0.733 | -1.099 | [0 - 0.5] |
returnOnAssetsTTM | -0.0178 | 1.200 | -0.593 | -0.711 | [0 - 0.3] |
returnOnEquityTTM | -0.0349 | 1.500 | -1.499 | -2.25 | [0.1 - 1] |
payoutRatioTTM | -1.853 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 2.85 | 0.800 | 0.735 | 0.588 | [1 - 3] |
quickRatioTTM | 1.333 | 0.800 | 6.87 | 5.49 | [0.8 - 2.5] |
cashRatioTTM | 0.454 | 1.500 | 8.59 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.321 | -1.500 | 4.64 | -6.96 | [0 - 0.6] |
interestCoverageTTM | 0.767 | 1.000 | -0.827 | -0.827 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.559 | 2.00 | 9.81 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.358 | 2.00 | 9.82 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.668 | -1.500 | 7.33 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.564 | 1.000 | 3.93 | 3.93 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0225 | 1.000 | -1.551 | -1.551 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.126 | 1.000 | -0.411 | -0.411 | [0.2 - 2] |
assetTurnoverTTM | 0.485 | 0.800 | -0.0986 | -0.0788 | [0.5 - 2] |
Total Score | 3.80 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -157.77 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0349 | 2.50 | -0.964 | -2.25 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.358 | 2.00 | 9.88 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.559 | 2.00 | 9.81 | 10.00 | [0 - 30] |
payoutRatioTTM | -1.853 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | -2 682.07 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0835 | 1.000 | -0.412 | 0 | [0.1 - 0.5] |
Total Score | -1.282 |
Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators